KRAS and neoplasm: As demonstrated by Dai et al., the oxidative stress caused by ferroptosis in tumor cells will trigger the release of oncogenic KRAS protein, which is then taken up by local tumor-associated macrophages, causing them to switch to an M2 phenotype [39].